Safety profile of IBD: lymphoma risks
- PMID: 19944800
- DOI: 10.1016/j.mcna.2009.08.015
Safety profile of IBD: lymphoma risks
Abstract
This article describes the cancer risks of commonly used inflammatory bowel disease (IBD) medications, with an emphasis on hematologic malignancy risks. The increasing use of immunosuppressant therapies in the treatment of IBD has raised this question to an even greater importance. Studies evaluating these medications are complicated due to varying disease severity and concomitant use of other immunosuppressant medication. The potential risks of all therapies must be weighed against the benefits these therapies can offer these patients.
Republished from
-
Safety profile of IBD: lymphoma risks.Gastroenterol Clin North Am. 2009 Dec;38(4):669-89. doi: 10.1016/j.gtc.2009.07.004. Gastroenterol Clin North Am. 2009. PMID: 19913208 Review.
Similar articles
-
Safety profile of IBD: lymphoma risks.Gastroenterol Clin North Am. 2009 Dec;38(4):669-89. doi: 10.1016/j.gtc.2009.07.004. Gastroenterol Clin North Am. 2009. PMID: 19913208 Review.
-
Safety profile of IBD therapeutics: infectious risks.Med Clin North Am. 2010 Jan;94(1):115-33. doi: 10.1016/j.mcna.2009.08.016. Med Clin North Am. 2010. PMID: 19944801
-
Clostridium difficile and inflammatory bowel disease.Med Clin North Am. 2010 Jan;94(1):135-53. doi: 10.1016/j.mcna.2009.08.013. Med Clin North Am. 2010. PMID: 19944802
-
Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD.Med Clin North Am. 2010 Jan;94(1):35-52. doi: 10.1016/j.mcna.2009.10.002. Med Clin North Am. 2010. PMID: 19944797
-
Role of oral medications in spasticity management.PM R. 2009 Sep;1(9):839-41. doi: 10.1016/j.pmrj.2009.07.014. PM R. 2009. PMID: 19769918 Review.
Cited by
-
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review.J Gastrointest Oncol. 2022 Oct;13(5):2565-2582. doi: 10.21037/jgo-22-138. J Gastrointest Oncol. 2022. PMID: 36388654 Free PMC article.
LinkOut - more resources
Full Text Sources